Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India

(2014) Sakib Burza et al.   PLoS Neglected Tropical Diseases

Visceral Leishmaniasis Prevalence and Associated Risk Factors in the Saran District of Bihar, India, from 2009 to July of 2011

(2013) Diana Perry et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison

(2013) Gláucia F. Cota et al.   PLoS Neglected Tropical Diseases

Clinical Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India

(2012) Vidya Nand Rabi Das et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

(2012) S. Sundar et al.   CLINICAL INFECTIOUS DISEASES

Liposomal amphotericin B as a treatment for human leishmaniasis

(2012) Manica Balasegaram et al.   EXPERT OPINION ON EMERGING DRUGS

Treatment of Visceral Leishmaniasis: Model-Based Analyses on the Spread of Antimony-Resistant L. donovani in Bihar, India

(2012) Anette Stauch et al.   PLoS Neglected Tropical Diseases

Phase IV Trial of Miltefosine in Adults and Children for Treatment of Visceral Leishmaniasis (Kala-Azar) in Bangladesh

(2011) Mahmudur Rahman et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India

(2010) Prabhat K. Sinha et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Socio–economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis

(2010) M. Boelaert et al.   ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY

Combination therapy for visceral leishmaniasis

(2010) Johan van Griensven et al.   LANCET INFECTIOUS DISEASES

Developments in the treatment of visceral leishmaniasis

(2009) Margriet Leontine den Boer et al.   EXPERT OPINION ON EMERGING DRUGS

Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis

(2009) Kishor M. Wasan et al.   JOURNAL OF INFECTIOUS DISEASES

Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar

(2008) S. Sundar et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH